The Spectrum of Lung Involvement in Collagen Vascular-Like Diseases Following Allogeneic Hematopoietic Stem Cell Transplantation-Reference-Cited by-同舟云学术

The Spectrum of Lung Involvement in Collagen Vascular-Like Diseases Following Allogeneic Hematopoietic Stem Cell Transplantation

Published:2011-03 Issue:2 Volume:90 Page:146-157
ISSN:0025-7974
Container-title:Medicine
language:en
Short-container-title:

Author:

Bergeron Anne,Bengoufa Djaouida,Feuillet Séverine,Meignin Véronique,de Latour Régis Peffault,Rybojad Michel,Gossot Dominique,Azoulay Elie,Socié Gérard,Tazi Abdellatif

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine

Reference58 articles.

1. Chronic lung disease after hematopoietic stem cell transplantation.;Afessa;Clin Chest Med,2005

2. Polymyositis and myocarditis after donor lymphocyte infusion.;Ahn;Int J Hematol,2009

3. Dermatomyositis-like muscle pathology in patients with chronic graft-versus-host disease.;Allen;Muscle Nerve,2009

4. Microscopic polyangiitis sparing the kidneys in a long-term survivor after allogeneic bone marrow transplantation and graft-versus-host disease.;Almoallim;Clin Rheumatol,2005

5. Pivotal clinical dilemmas in collagen vascular diseases associated with interstitial lung involvement.;Antoniou;Eur Respir J,2009

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pulmonary Manifestations of Hematological Malignancies;Orphan Lung Diseases;2023

2. Diagnostic Evaluation of Pulmonary Disease Following Hematopoietic Stem Cell Transplantation;Pulmonary and Critical Care Considerations of Hematopoietic Stem Cell Transplantation;2023

3. Late-Onset Interstitial Lung Disease Following Allogeneic Hematopoietic Stem Cell Transplantation;Pulmonary and Critical Care Considerations of Hematopoietic Stem Cell Transplantation;2023

4. Interstitial lung diseases after hematopoietic stem cell transplantation: New pattern of lung chronic graft-versus-host disease?;Bone Marrow Transplantation;2022-10-29

5. Pulmonale Manifestation hämatoonkologischer Erkrankungen und Therapien;Seltene Lungenerkrankungen;2022